Page 19 of articles about vaccine

Maternally derived antibodies at the time of porcine circovirus type 2 vaccination: does it matter?

One issue is to overcome maternal immunity, which is true for all PCV2 vaccines in the market, and another is whether the most from these vaccines is achieved independently of the PCV2 antibody titre at vaccination

Home

Press releases

A piglet claim for CIRCOVAC® in Europe

On November 29th 2010, CIRCOVAC was granted a European marketing authorization for use in piglets. CIRCOVAC is now the first PCVD vaccine available worldwide for the vaccination of both sows and piglets; it is registered in Europe, Brazil, Mexico and Thailand.

Home

Abstract

Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae

rCap expressed in T. ni larvae could be a cost-effective PCV2 vaccine candidate to be tested under field conditions.

Home

News

South Korea expands vaccination areas to combat FMD

South Korea on Monday decided to expand areas where vaccination will be administered in the face of the country's severest outbreak of foot-and-mouth disease (FMD), the government said.

Home

News

European Union - Commission supplies Foot and Mouth Disease vaccine to Zambia

The European Commission has sent a consignment of Foot and Mouth Disease (FMD) vaccine to Zambia in order to help the African nation's efforts in fighting an outbreak of the disease in the northern part of the country. The consignment consists of 80,000 doses of FMD vaccine.

Home

News

China - PCV vaccine developed in Henan

A vaccine against porcine circovirus (PCV) has been successfully developed in Henan Province and granted the National Registration Certificate for New Veterinary Drug and the production approval document number as well as the approval to be marketed as a national-level new veterinary drug of the second category from the Ministry of Agriculture (MOA).

Home

Press releases

Intervet/Schering-Plough Animal Health expands veterinary vaccine manufacturing facility at biosciences center Boxmeer

Intervet/Schering-Plough Animal Health announced that it has opened a specialized filling and freeze-drying unit for veterinary vaccines at its Biosciences Center Boxmeer in the Netherlands. The opening of the Central Filling and Freeze-drying Department was performed by her Royal Highness Princess Máxima of the Netherlands in the presence of His Excellency the Minister of Economic Affairs, Agriculture and Innovation, Maxime Verhagen, and other guests.

Home

News

Mongolia - MNT300 Million for FMD

As the spread of FMD still continued and the disease outbreak risk is still high, the Cabinet has decided to allocate MNT300 million for the purchase of 600,000 dozes of vaccine from Russia and for injection costs.

Home

Article

Sanitary Equilibrium: The role of PCV2 vaccines

The most common problems are due to interference with maternal antibodies and coincidence of vaccination with a recirculation of PRRS: viremic animals.

Home

NutritionAbstract

The effect of supplementing dry feed with a nutritional gel additive at the time of vaccination on nursery pig behaviour

A nutritional gel supplementation reduces the negative impact of vaccination on piglet behaviour.

Home

Abstract

Dynamics and longevity of maternally-acquired antibodies to Taenia solium in piglets born to naturally infected sows

The observed variations in the level of maternally-acquired Abs amongst piglets will pose a major challenge to the implementation of vaccination programmes against T. solium cysticercosis.

Home

Press releases

Day one Mycoplasma hyopneumoniae vaccination now possible with RespiSure-ONE®

Pork producers in US can now vaccinate for mycoplasmal pneumonia at day one.

Home

Press releases

Intervet/Schering-Plough animal health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swine

Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and safe as separate use of these vaccines.

Home

Press releases

IDRI And Merial Enter Into Research Collaboration

Global animal health company Merial Ltd. and non-profit biotechnology organization the Infectious Disease Research Institute (IDRI) today announce they have agreed to cooperate regarding the research and development of certain vaccines for animals.

Home

Press releases

Biolex and Merial Broaden Collaboration

Biolex Therapeutics, Inc and Merial Ltd today announced that they have entered into a new, broad-ranging research and development collaboration to produce innovative veterinary vaccines.

Home

Press releases

First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union

The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo®.